Literature DB >> 15774912

Blepharokeratoconjunctivitis in children: diagnosis and treatment.

M Viswalingam1, S Rauz, N Morlet, J K G Dart.   

Abstract

AIM: Blepharokeratoconjunctivitis (BKC) is a poorly described entity in children. This study characterises this syndrome in childhood and evaluates epidemiology, clinical grading, and treatment strategies.
METHODS: 44 children (20 white, 22 Asian, 2 Middle Eastern, median age 5.4 (range 1-14) years) with a diagnosis of BKC were followed for a median of 7 years. Diagnostic criteria included recurrent episodes of chronic red eye, watering, photophobia, blepharitis including recurrent styes or meibomian cysts, and a keratitis. Clinical features were graded as mild, moderate, or severe. The lids and conjunctiva were cultured. The treatment regimen incorporated lid hygiene, topical and/or systemic antibiotics, and topical corticosteroids.
RESULTS: The disease was most severe in the Asian and Middle Eastern children (p <0.001), who had a statistically higher risk of subepithelial punctate keratitis (p = 0.008), corneal vascularisation (p <0.001), and marginal corneal ulcerations (p = 0.003), than the white group. 15 children had culture positive lid swabs. Most children had a reduction in symptoms and signs with treatment, and progression of disease after the age of 8 was rare.
CONCLUSIONS: BKC in children can be defined as "a syndrome usually associated with anterior or posterior lid margin blepharitis, accompanied by episodes of conjunctivitis, and a keratopathy including punctate erosions, punctate keratitis, phlyctenules, marginal keratitis, and ulceration." BKC is common in children in a tertiary referral corneal and external diseases clinic, with the more severe manifestations in the Asian and Middle Eastern populations. Therapy is effective and loss of sight can be prevented in most cases.

Entities:  

Mesh:

Year:  2005        PMID: 15774912      PMCID: PMC1772603          DOI: 10.1136/bjo.2004.052134

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  Oral erythromycin treatment for childhood blepharokeratitis.

Authors:  D M Meisler; M B Raizman; E I Traboulsi
Journal:  J AAPOS       Date:  2000-12       Impact factor: 1.220

Review 2.  History of macrolide use in pediatrics.

Authors:  J O Klein
Journal:  Pediatr Infect Dis J       Date:  1997-04       Impact factor: 2.129

3.  Orally administered tetracycline for phlyctenular keratoconjunctivitis.

Authors:  G W Zaidman; S I Brown
Journal:  Am J Ophthalmol       Date:  1981-08       Impact factor: 5.258

4.  The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci.

Authors:  J M Dougherty; J P McCulley; R E Silvany; D R Meyer
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-10       Impact factor: 4.799

5.  Classification of chronic blepharitis.

Authors:  J P McCulley; J M Dougherty; D G Deneau
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

  5 in total
  17 in total

Review 1.  Interventions for chronic blepharitis.

Authors:  Kristina Lindsley; Sueko Matsumura; Elham Hatef; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Successful treatment of staphylococcus-associated marginal keratitis with topical cyclosporine.

Authors:  Fatih Ozcura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-04       Impact factor: 3.117

Review 3.  Topical treatments for blepharokeratoconjunctivitis in children.

Authors:  Michael O'Gallagher; Catey Bunce; Melanie Hingorani; Frank Larkin; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2017-02-07

4.  A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis.

Authors:  Yazmin Yactayo-Miranda; Christopher N Ta; Lisa He; Thomas C Kreutzer; Martin M Nentwich; Anselm Kampik; Herminia Mino de Kaspar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-11       Impact factor: 3.117

5.  Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome.

Authors:  A Rodríguez-García; S González-Godínez; S López-Rubio
Journal:  Eye (Lond)       Date:  2015-12-04       Impact factor: 3.775

Review 6.  Systemic treatment for blepharokeratoconjunctivitis in children.

Authors:  Michael O'Gallagher; Marina Banteka; Catey Bunce; Frank Larkin; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2016-05-30

7.  Oral antibiotics for chronic blepharitis.

Authors:  Neil Onghanseng; Sueko M Ng; Muhammad Sohail Halim; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09

8.  Efficacy of azithromycin 1.5% eye drops in childhood ocular rosacea with phlyctenular blepharokeratoconjunctivitis.

Authors:  Serge Doan; Eric Gabison; Frédéric Chiambaretta; Melissa Touati; Isabelle Cochereau
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-02-22

9.  Topical cyclosporin as an alternative treatment for vision threatening blepharokeratoconjunctivitis: a case report.

Authors:  Abdul-Salim Ismail; Rohana Taharin; Zunaina Embong
Journal:  Int Med Case Rep J       Date:  2012-06-27

Review 10.  Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections.

Authors:  Sixto M Leal; Kyle G Rodino; W Craig Fowler; Peter H Gilligan
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.